BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6945618)

  • 1. Phenolsulfotransferase.
    Psychopharmacol Bull; 1981 Jul; 17(3):43-52. PubMed ID: 6945618
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of phenolsulfotransferase activity in microvascular endothelial cells: formation of 5-HT-O-sulfate in intact cells.
    Robinson-White A; Costa JL; Launay JM; Fay DD
    Microvasc Res; 1988 May; 35(3):363-7. PubMed ID: 3164826
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet phenolsulfotransferase activity and the headache spectrum.
    Sandler M; Littlewood JT; Glover V; Peatfield R; Petty R; Rose FC
    Psychopharmacol Bull; 1984; 20(3):539-41. PubMed ID: 6591229
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenolsulphotransferase.
    Lancet; 1982 Feb; 1(8270):490. PubMed ID: 6121148
    [No Abstract]   [Full Text] [Related]  

  • 5. The platelet phenolsulfotransferase is not indispensable for the sulfoconjugation of plasma catecholamines.
    Kuchel O; Buu NT; Neemeh J
    Endocr Res; 1985; 11(3-4):225-32. PubMed ID: 3869101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of human platelets for phenolsulfotransferase activity determination: the method of choice.
    Soliman H; Oset-Gasque MJ; Callebert J; Launay JM; Tabuteau F; Dreux C
    Thromb Res; 1987 Feb; 45(3):279-84. PubMed ID: 3477882
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of probenecid on rat brain phenolsulfotransferase activity using dopamine as substrate.
    Kao GY; Elchisak MA
    Pharmacology; 1987; 34(5):259-63. PubMed ID: 3475732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the platelet phenolsulfotransferase involved in the sulfoconjugation of plasma catecholamines?
    Romain Y; Demassieux S; D'Angelo G; Gyger M; Carrière S
    Can J Physiol Pharmacol; 1986 Sep; 64(9):1197-201. PubMed ID: 3465424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of the role of phenolsulfotransferase in the disposition of serotonin in human platelets: implications for a novel therapeutic strategy against depression.
    Costa JL; Launay JM; Kirk KL
    Med Hypotheses; 1983 Mar; 10(3):231-46. PubMed ID: 6576226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of some biological trait markers in migraine: deuterated tyramine challenge test, monoamine oxidase, phenolsulfotransferase and plasma and urinary biogenic amine and acid metabolite levels.
    Davis BA; Dawson B; Boulton AA; Yu PH; Durden DA
    Headache; 1987 Jul; 27(7):384-9. PubMed ID: 3477534
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-dependent shifts in the sulfation and glucuronidation of phenolic compounds in the rat in vivo and in isolated hepatocytes. The role of saturation of phenolsulfotransferase.
    Koster H; Halsema I; Scholtens E; Knippers M; Mulder GJ
    Biochem Pharmacol; 1981 Sep; 30(18):2569-75. PubMed ID: 6946775
    [No Abstract]   [Full Text] [Related]  

  • 12. [Platelet phenol sulfotransferase activities: a migraine marker?].
    Launay JM; Soliman H; Pradalier A; Dry J; Dreux C
    Therapie; 1988; 43(4):273-7. PubMed ID: 3055405
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple forms of phenolsulphotransferase in human tissues: selective inhibition by dichloronitrophenol.
    Rein G; Glover V; Sandler M
    Biochem Pharmacol; 1982 May; 31(10):1893-7. PubMed ID: 6954952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetaminophen and phenol: substrates for both a thermostable and a thermolabile form of human platelet phenol sulfotransferase.
    Reiter C; Weinshilboum RM
    J Pharmacol Exp Ther; 1982 Apr; 221(1):43-51. PubMed ID: 6950087
    [No Abstract]   [Full Text] [Related]  

  • 15. Arylsulfotransferase IV catalyzed sulfation of 1-naphthalenemethanol.
    Duffel MW; Janss MN
    Adv Exp Med Biol; 1986; 197():415-22. PubMed ID: 3464166
    [No Abstract]   [Full Text] [Related]  

  • 16. Human platelet phenolsulphotransferase M and P: substrate specificities and correlation with in vivo sulphoconjugation of paracetamol and salicylamide.
    Bonham Carter SM; Rein G; Glover V; Sandler M; Caldwell J
    Br J Clin Pharmacol; 1983 Mar; 15(3):323-30. PubMed ID: 6573904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of phenolsulphotransferase P by certain food constituents.
    Gibb C; Glover V; Sandler M
    Lancet; 1986 Apr; 1(8484):794. PubMed ID: 2870281
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of human brain phenolsulphotransferase.
    Rein G; Glover V; Sandler M
    J Neurochem; 1984 Jan; 42(1):80-5. PubMed ID: 6580382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does sulfate conjugation contribute to the metabolic inactivation of catecholamines in humans?
    Roth JA; Rivett AJ
    Biochem Pharmacol; 1982 Oct; 31(19):3017-21. PubMed ID: 6756408
    [No Abstract]   [Full Text] [Related]  

  • 20. Human platelet phenolsulfotransferases: cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form.
    Jones AL; Hagen M; Coughtrie MW; Roberts RC; Glatt H
    Biochem Biophys Res Commun; 1995 Mar; 208(2):855-62. PubMed ID: 7695643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.